Verity & Verity Llc decreased its stake in Novartis A G (NVS) by 19.83% based on its latest 2019Q2 regulatory filing with the SEC. Verity & Verity Llc sold 19,145 shares as the company’s stock rose 11.81% . The institutional investor held 77,383 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $7.07M, down from 96,528 at the end of the previous reported quarter. Verity & Verity Llc who had been investing in Novartis A G for a number of months, seems to be less bullish one the $197.26B market cap company. The stock decreased 2.79% or $2.5 during the last trading session, reaching $86.99. About 2.35M shares traded or 23.59% up from the average. Novartis AG (NYSE:NVS) has risen 22.04% since September 14, 2018 and is uptrending. It has outperformed by 22.04% the S&P500. Some Historical NVS News: 05/04/2018 – Samsung Bioepis Settles Patent Disputes with AbbVie, Clearing the Way for the Commercialization of SB5 (Adalimumab) in All; 03/05/2018 – IGNORE: FDA TISAGENLECLEUCEL APPROVAL ANNOUNCED MAY 1; 27/03/2018 – #2 Reshaping Novartis into a more aggressive pharma giant, Vas Narasimhan bags a $13B consumer sale ahead of bolt-on deals $NVS $GSK; 28/03/2018 – Tasigna Lawsuits Mount, as Plaintiff in Washington State Accuses Novartis of Failing to Warn that Leukemia Drug Had Been Linked to Atherosclerosis-Related Conditions, Bernstein Liebhard LLP Reports; 09/04/2018 – Novartis Expects AveXis Deal to Close Mid 2018; 16/05/2018 – Top Novartis lawyer exits over Trump attorney deal error; 10/04/2018 – BRIEF-Moody’s Says $8.7 bln Acquisition Of Avexis Strengthens Novartis’s Pipeline In Gene Therapy; 09/04/2018 – Novartis shells out $8.7 bln to buy AveXis; 01/05/2018 – Novartis: Hart-Scott-Rodino Antitrust Waiting Period for Avexis Tender Offre Expired; 16/05/2018 – Novartis Says General Counsel to Retire Over Cohen Payments
Quantum Capital Management increased its stake in Perceptron Inc (PRCP) by 60.01% based on its latest 2019Q2 regulatory filing with the SEC. Quantum Capital Management bought 85,328 shares as the company’s stock declined 43.38% . The institutional investor held 227,519 shares of the capital goods company at the end of 2019Q2, valued at $1.01M, up from 142,191 at the end of the previous reported quarter. Quantum Capital Management who had been investing in Perceptron Inc for a number of months, seems to be bullish on the $50.63 million market cap company. The stock increased 1.35% or $0.07 during the last trading session, reaching $5.25. About 32,407 shares traded. Perceptron, Inc. (NASDAQ:PRCP) has declined 61.51% since September 14, 2018 and is downtrending. It has underperformed by 61.51% the S&P500. Some Historical PRCP News: 08/03/2018 Perceptron Announces New Robot Guidance Project Wins; 07/05/2018 – Perceptron 3Q EPS 11c; 07/05/2018 – PERCEPTRON INC – REAFFIRMS PREVIOUS GUIDANCE OF MID-SINGLE DIGIT REVENUE GROWTH FOR FISCAL YEAR 2018; 07/05/2018 – Perceptron Reaffirms Mid-Single Digit Rev Growth for FY 2018; 07/05/2018 – Perceptron Sees 4Q Rev $20M-$23M; 19/04/2018 – DJ Perceptron Inc, Inst Holders, 1Q 2018 (PRCP); 07/05/2018 – PERCEPTRON INC – BACKLOG AT QTR-END INCREASED 5.3% TO $51.2 MLN
Investors sentiment increased to 1.2 in Q2 2019. Its up 0.67, from 0.53 in 2019Q1. It is positive, as 3 investors sold PRCP shares while 7 reduced holdings. 5 funds opened positions while 7 raised stakes. 6.65 million shares or 2.68% less from 6.84 million shares in 2019Q1 were reported. Northern Corp holds 0% of its portfolio in Perceptron, Inc. (NASDAQ:PRCP) for 32,809 shares. Harbert Fund stated it has 987,091 shares or 6.43% of all its holdings. Ancora Limited Liability Com stated it has 0.01% in Perceptron, Inc. (NASDAQ:PRCP). Renaissance Llc accumulated 0% or 613,130 shares. Clarivest Asset Mngmt Ltd Limited Liability Company has invested 0% of its portfolio in Perceptron, Inc. (NASDAQ:PRCP). Tower Research Capital Ltd Liability Corp (Trc) accumulated 130 shares. Penbrook Limited Com holds 0.8% or 167,393 shares. Jacobs Levy Equity Management invested in 10,087 shares or 0% of the stock. Comml Bank Of America De has 0% invested in Perceptron, Inc. (NASDAQ:PRCP) for 375 shares. Ariel Ltd Limited Liability Company invested in 1.64 million shares or 0.09% of the stock. Wells Fargo & Mn holds 0% of its portfolio in Perceptron, Inc. (NASDAQ:PRCP) for 250,836 shares. Comml Bank Of Mellon has 0% invested in Perceptron, Inc. (NASDAQ:PRCP) for 42,393 shares. Rbf Cap Ltd Llc holds 0.03% in Perceptron, Inc. (NASDAQ:PRCP) or 77,841 shares. Acadian Asset Mngmt Ltd Liability Co accumulated 2,137 shares. Keybank National Association Oh reported 0% stake.
Since June 5, 2019, it had 3 buys, and 0 selling transactions for $31,015 activity. The insider Van Valkenburg Richard bought 5,000 shares worth $22,200.
More notable recent Perceptron, Inc. (NASDAQ:PRCP) news were published by: Nasdaq.com which released: “Flir Systems (FLIR) Q4 Earnings Surpass Estimates – Nasdaq” on February 13, 2019, also Nasdaq.com with their article: “Perceptron Wins AutoGauge®ACF Order at Global Appliance Manufacturer – Nasdaq” published on August 22, 2019, Finance.Yahoo.com published: “Perceptron Inc (PRCP) Files 10-K for the Fiscal Year Ended on June 30, 2019 – Yahoo Finance” on September 12, 2019. More interesting news about Perceptron, Inc. (NASDAQ:PRCP) were released by: Nasdaq.com and their article: “Why Is Itron (ITRI) Down 12.5% Since Last Earnings Report? – Nasdaq” published on March 29, 2019 as well as Nasdaq.com‘s news article titled: “Pre-Market Most Active for Jun 6, 2019 : CLDR, AMD, ENPH, HOME, IFRX, QQQ, NIO, SFIX, GRFS, CIEN, FCAU, GFI – Nasdaq” with publication date: June 06, 2019.
Quantum Capital Management, which manages about $700.30 million and $182.67M US Long portfolio, decreased its stake in Northwest Pipe Co (NASDAQ:NWPX) by 21,199 shares to 68,577 shares, valued at $1.77 million in 2019Q2, according to the filing. It also reduced its holding in Zimmer Biomet Hldgs Inc (ZMH) by 3,058 shares in the quarter, leaving it with 9,748 shares, and cut its stake in Vanguard Group (VIG).
Verity & Verity Llc, which manages about $217.83 million and $460.13M US Long portfolio, upped its stake in Enbridge Inc (NYSE:ENB) by 104,154 shares to 141,869 shares, valued at $5.12 million in 2019Q2, according to the filing. It also increased its holding in Ameriprise Finl Inc (NYSE:AMP) by 15,930 shares in the quarter, for a total of 33,085 shares, and has risen its stake in Prudential Finl Inc (NYSE:PRU).
More notable recent Novartis AG (NYSE:NVS) news were published by: Globenewswire.com which released: “ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm – GlobeNewswire” on August 21, 2019, also Finance.Yahoo.com with their article: “Hereâ€™s What Hedge Funds Think About Novartis AG (NVS) – Yahoo Finance” published on June 07, 2019, Benzinga.com published: “ROSEN, A LEADING LAW FIRM, Continues To Investigate Securities Claims Against Novartis AG â€“ NVS – Benzinga” on September 07, 2019. More interesting news about Novartis AG (NYSE:NVS) were released by: Fool.com and their article: “Keep Your Eye on These 4 Healthcare Stocks – The Motley Fool” published on August 23, 2019 as well as Streetinsider.com‘s news article titled: “Novartis (NVS) Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing MS – StreetInsider.com” with publication date: September 13, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.